DAVIS COMMODITIES LTD-A (DTCK) Fundamental Analysis & Valuation

NASDAQ:DTCK • KYG2677P1054

0.0829 USD
-0.01 (-12.18%)
At close: Mar 5, 2026
0.0824 USD
0 (-0.6%)
After Hours: 3/5/2026, 8:00:02 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This DTCK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

1

DTCK gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 38 industry peers in the Consumer Staples Distribution & Retail industry. While DTCK seems to be doing ok healthwise, there are quite some concerns on its profitability. DTCK has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. DTCK Profitability Analysis

1.1 Basic Checks

  • In the past year DTCK has reported negative net income.
  • DTCK had a negative operating cash flow in the past year.
  • DTCK had positive earnings in 4 of the past 5 years.
  • In multiple years DTCK reported negative operating cash flow during the last 5 years.
DTCK Yearly Net Income VS EBIT VS OCF VS FCFDTCK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

  • DTCK has a Return On Assets of -8.60%. This is amonst the worse of the industry: DTCK underperforms 86.84% of its industry peers.
  • With a Return On Equity value of -51.59%, DTCK is not doing good in the industry: 84.21% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -8.6%
ROE -51.59%
ROIC N/A
ROA(3y)3.8%
ROA(5y)6.88%
ROE(3y)11.56%
ROE(5y)56.46%
ROIC(3y)N/A
ROIC(5y)N/A
DTCK Yearly ROA, ROE, ROICDTCK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 50 -50 100 150 200

1.3 Margins

  • DTCK has a worse Gross Margin (2.18%) than 97.37% of its industry peers.
  • DTCK's Gross Margin has declined in the last couple of years.
  • DTCK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 2.18%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-34.61%
GM growth 5YN/A
DTCK Yearly Profit, Operating, Gross MarginsDTCK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 2 -2 4 6

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. DTCK Health Analysis

2.1 Basic Checks

  • DTCK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DTCK has about the same amout of shares outstanding than it did 1 year ago.
  • The debt/assets ratio for DTCK is higher compared to a year ago.
DTCK Yearly Shares OutstandingDTCK Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 5M 10M 15M 20M
DTCK Yearly Total Debt VS Total AssetsDTCK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • DTCK has an Altman-Z score of 5.48. This indicates that DTCK is financially healthy and has little risk of bankruptcy at the moment.
  • DTCK's Altman-Z score of 5.48 is amongst the best of the industry. DTCK outperforms 81.58% of its industry peers.
  • A Debt/Equity ratio of 0.18 indicates that DTCK is not too dependend on debt financing.
  • DTCK has a better Debt to Equity ratio (0.18) than 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Altman-Z 5.48
ROIC/WACCN/A
WACC8.05%
DTCK Yearly LT Debt VS Equity VS FCFDTCK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M 4M 6M 8M 10M

2.3 Liquidity

  • DTCK has a Current Ratio of 1.02. This is a normal value and indicates that DTCK is financially healthy and should not expect problems in meeting its short term obligations.
  • DTCK's Current ratio of 1.02 is on the low side compared to the rest of the industry. DTCK is outperformed by 63.16% of its industry peers.
  • DTCK has a Quick Ratio of 1.02. This is a bad value and indicates that DTCK is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.92, DTCK is in the better half of the industry, outperforming 73.68% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 0.92
DTCK Yearly Current Assets VS Current LiabilitesDTCK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. DTCK Growth Analysis

3.1 Past

  • DTCK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -244.03%.
  • Looking at the last year, DTCK shows a very negative growth in Revenue. The Revenue has decreased by -11.72% in the last year.
  • Measured over the past years, DTCK shows a very negative growth in Revenue. The Revenue has been decreasing by -11.99% on average per year.
EPS 1Y (TTM)-244.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.88%
Revenue 1Y (TTM)-11.72%
Revenue growth 3Y-11.99%
Revenue growth 5YN/A
Sales Q2Q%42.11%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
DTCK Yearly Revenue VS EstimatesDTCK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

Find the best growth stocksShow best growing peers

0

4. DTCK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DTCK. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DTCK Price Earnings VS Forward Price EarningsDTCK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DTCK Per share dataDTCK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DTCK Dividend Analysis

5.1 Amount

  • DTCK does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DTCK Fundamentals: All Metrics, Ratios and Statistics

DAVIS COMMODITIES LTD-A

NASDAQ:DTCK (3/5/2026, 8:00:02 PM)

After market: 0.0824 0 (-0.6%)

0.0829

-0.01 (-12.18%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)12-23
Earnings (Next)04-28
Inst Owners1.11%
Inst Owner ChangeN/A
Ins Owners44.43%
Ins Owner ChangeN/A
Market Cap2.27M
Revenue(TTM)227.41M
Net Income(TTM)-3.49M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.34
P/tB 0.34
EV/EBITDA N/A
EPS(TTM)-0.14
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.12
FCFYN/A
OCF(TTM)-0.12
OCFYN/A
SpS8.31
BVpS0.25
TBVpS0.25
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.6%
ROE -51.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 2.18%
FCFM N/A
ROA(3y)3.8%
ROA(5y)6.88%
ROE(3y)11.56%
ROE(5y)56.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-34.61%
GM growth 5YN/A
F-Score1
Asset Turnover5.61
Health
Industry RankSector Rank
Debt/Equity 0.18
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.32%
Cap/Sales 0%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 0.92
Altman-Z 5.48
F-Score1
WACC8.05%
ROIC/WACCN/A
Cap/Depr(3y)166.43%
Cap/Depr(5y)103.86%
Cap/Sales(3y)0.05%
Cap/Sales(5y)0.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-244.03%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-96.88%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-11.72%
Revenue growth 3Y-11.99%
Revenue growth 5YN/A
Sales Q2Q%42.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-270.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-22.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-37.72%
OCF growth 3YN/A
OCF growth 5YN/A

DAVIS COMMODITIES LTD-A / DTCK FAQ

What is the ChartMill fundamental rating of DAVIS COMMODITIES LTD-A (DTCK) stock?

ChartMill assigns a fundamental rating of 1 / 10 to DTCK.


What is the valuation status for DTCK stock?

ChartMill assigns a valuation rating of 0 / 10 to DAVIS COMMODITIES LTD-A (DTCK). This can be considered as Overvalued.


How profitable is DAVIS COMMODITIES LTD-A (DTCK) stock?

DAVIS COMMODITIES LTD-A (DTCK) has a profitability rating of 1 / 10.


Can you provide the financial health for DTCK stock?

The financial health rating of DAVIS COMMODITIES LTD-A (DTCK) is 4 / 10.